Trading status Status de
  • Prices realtime
    • Indizes
      • Germany 40
      • MID Germany 50
      • TEC Germany 30
      • USA 30
      • EUROPE 50
      • TEC USA 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 12694
  • 12695
  • 12696
  • …
  • ›
  • »

2025-10-24

Form 8.5 (EPT/RI)-Inspecs Group PLC

2025-10-24

CVS Group plans move to Main Market and £20 million share buyback

2025-10-24

Svenska Cellulosa Q3 Result Drops As Lower Prices, Negative Foreign Exchange Impact Hurt

2025-10-24

Prevas publishes the interim report for the third quarter of 2025

2025-10-24

AFARAK GROUP INVESTS IN PRODUCTION OF METALLURGICAL GRADE CHROME ORE CONCENTRATE

2025-10-24

Altor divests all its shares in RevolutionRace

2025-10-24

Want to invest in AI shares but worried about a bubble? Check out this UK value stock

2025-10-24

Sanlam plans private markets push as it eyes SA′s rich

2025-10-24

Softcat upgraded after a strong finish to the year

2025-10-24

Bambuser AB: Bambuser Q3 2025: Continued Operational Progress and Enterprise Wins Reinforce Foundation for the Next Growth Phase

2025-10-24

Svenska Cellulosa Aktiebolaget SCA Profit Declines In Q3

2025-10-24

Karolinska Development′s portfolio company SVF Vaccines presents positive data from a preclinical study of SVF-001 in chronic hepatitis B and D

  • «
  • ‹
  • …
  • 12694
  • 12695
  • 12696
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies